SET DE REACTIVOS PARACREATINA QUINASA LÍQUIDA.
Mexico·Clase I·III. DIAGNOSTIC AGENTS·DICIPA, S.A. DE C.V.·Registered May 25, 2022SETDEREACTIVOSPARALADETERMINACIÓNCUANTITATIVADELAACTIVIDADDECREATININAQUINASAPRESENTEENELSUERO. AGENTEDEDIAGNÓSTICOPARAUSOINVITRO.PARAUSOEXCLUSIVODELABORATORIOSCLÍNICOSODEGABINETE.
SET of reagents for the quantitative determination of the activity of creatinine kinase present in serum. DIAGNOSTIC AGENTFOR use. FOR exclusive use of clinical laboratories or cabinets.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- PRUEBA PARA LADETERMINACIÓN CUANTITATIVA DELAACTIVIDADDECREATINAQUINASA PRESENTE EN SUERO.
- Trade Name (English)
- TEST FOR THE QUANTITATIVE DETERMINATION OF THE ACTIVITY OF CREATINE KINASE PRESENT IN SERUM.
- Analysis ID
- 423R2022 SSA
- Registration Date
- May 25, 2022
- Name (Spanish)
- DICIPA, S.A. DE C.V.
- Name (English)
- DICIPA, S.A. DE C.V.
Access comprehensive regulatory information for SET DE REACTIVOS PARACREATINA QUINASA LÍQUIDA. (SET OF LIQUID PARACREATINE KINASE REAGENTS.) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 423R2022 SSA and manufactured by DICIPA, S.A. DE C.V.. The device was registered on May 25, 2022.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.